facebook linkedin twitter

Moderna Expanding Kids Vaccine Study to Better Assess Safety

July 27, 2021by Matthew Perrone and Linda A. Johnson, Associated Press
In this March 29, 2021 file photo, a worker readies syringes with the Moderna COVID-19 vaccine in Metairie, La. Moderna plans to expand the size of its study in younger children to better detect rare side effects. The company said Monday, July 26, 2021 it is in talks with the Food and Drug Administration to enroll more patients in its study of the vaccine in children under 12 years old and younger. (AP Photo/Gerald Herbert, File)

WASHINGTON (AP) — Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.

The company said it is in talks with the Food and Drug Administration to enroll more study participants under age 12. It had intended to test the vaccine in about 7,000 children, with some as young as 6 months. The Cambridge, Massachusetts-based company said via email it hasn’t decided on how many kids might be added. 

The announcement comes as U.S. COVID-19 cases are rising and schools prepare to welcome students back to classrooms. At the same time, regulators continue to review cases of a rare type of heart inflammation called myocarditis that has been reported in a small number of teenagers who got the Moderna or Pfizer shots.

Pfizer said on Monday that if it makes changes to its vaccine testing in children, it will provide an update then. The New York-based company is testing its vaccine in up to 4,500 children in the United States and Europe.

The FDA said in a statement it could not comment on its discussions with companies, but added “we do generally work with sponsors to ensure the number of participants in clinical trials are of adequate size to detect safety signals.”

The news was first reported by the New York Times.

U.S. officials and independent medical experts said last month the benefits of the vaccines far outweigh the risks of the side effect, which has been reported in several hundred people younger than 30. But any vaccine safety issues could slow uptake, particularly among parents wary of taking any health risk with their children.

Currently, Pfizer has the only U.S. vaccine authorized for children 12 years and up, while Moderna is expecting an FDA ruling on its application in the coming days.

While teens receive the same dose as adults, younger children may need smaller doses. That additional complexity adds time to drugmakers’ research and application timelines.

Moderna said Monday it expects to have enough data to apply for FDA authorization in younger kids by late this year or early 2022. 

Pfizer has previously said it expects to apply in September for children ages 5 through 11. Results for two younger age groups that began testing a little later should be available by October or November, according to the company.

___

 Johnson reported from Fairless Hills, Pennsylvania.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Health

September 24, 2021
by Tom Ramstack
CDC Director Overrides Vote to Broaden Eligibility for Vaccines

ATLANTA, Ga.-- Dr. Rochelle Walensky made an unusual break Friday from a U.S. Centers for Disease Control and Prevention advisory... Read More

ATLANTA, Ga.-- Dr. Rochelle Walensky made an unusual break Friday from a U.S. Centers for Disease Control and Prevention advisory panel by overruling its guidance on booster doses for the Pfizer/BioNTech's COVID-19 vaccine. The Advisory Committee on Immunization Practices approved the boosters Thursday for anyone 65... Read More

Biden Urges COVID-19 Booster Shots for Those Now Eligible

WASHINGTON (AP) - President Joe Biden on Friday urged those now eligible for COVID-19 booster shots to get the added... Read More

WASHINGTON (AP) - President Joe Biden on Friday urged those now eligible for COVID-19 booster shots to get the added protection a day after the Centers for Disease Control and Prevention endorsed the doses for millions of older or otherwise vulnerable Americans.  Opening a major new... Read More

September 23, 2021
by Reece Nations
Centers for Medicare and Medicaid Service to Distribute Federal Funding to Rural Hospitals

The Centers for Medicare and Medicaid Services is disbursing an initial amount of $2 million to four health care entities... Read More

The Centers for Medicare and Medicaid Services is disbursing an initial amount of $2 million to four health care entities in four states to bolster access to their services in underserved communities. Funds will be distributed to participating hospitals in rural areas to overhaul their health... Read More

September 22, 2021
by Tom Ramstack
Protecting Children During Pandemic Guides Policy at Congressional Hearing

WASHINGTON -- A congressional panel on Wednesday examined whether the federal government’s strategy is appropriate for protecting children during the... Read More

WASHINGTON -- A congressional panel on Wednesday examined whether the federal government’s strategy is appropriate for protecting children during the COVID-19 pandemic. Lawmakers asked about the potential for vaccinating children, having them return safely to school and whether they should wear masks. The update they sought... Read More

September 22, 2021
by Alexa Hornbeck
OSHA Will Issue Federal Heat Standard for U.S. Workplaces 

WASHINGTON -- Extreme heat has played a role in worsening health outcomes, especially for minority communities and for construction and... Read More

WASHINGTON -- Extreme heat has played a role in worsening health outcomes, especially for minority communities and for construction and farm workers at risk of heat stroke.  In response to rising temperatures due to climate change, the Occupational Safety and Health Administration is set to issue... Read More

September 22, 2021
by Alexa Hornbeck
NIH Invests $1.67 Million to Study How Vaccines Impact the Menstrual Cycle 

WASHINGTON -- The NIH recently invested $1.67 million in five institutions to explore the link between COVID-19 vaccines and menstruation... Read More

WASHINGTON -- The NIH recently invested $1.67 million in five institutions to explore the link between COVID-19 vaccines and menstruation changes, as some women are reporting irregular or missing menstrual periods after receiving a vaccine.  Only a few weeks after the NIH investment was released, an... Read More

News From The Well
scroll top